Skip to content

SS-31

Also called Elamipretide

Mitochondria-targeted tetrapeptide that binds cardiolipin on the inner membrane, stabilizing cristae and restoring efficient ATP production.

  • TypePeptide
  • FormInjectable, nasal
  • Researched forLongevity
SS-31 by AminoWell USA
Photo: AminoWell USA

Where to get SS-31

AminoWell USA
Injectable
Code CAMERON

Create a free account (21+), then use code CAMERON. This link is the injectable form. Other forms are not interchangeable with it.

Shop injectable at AminoWell USA

The short version

  • Why people research itMitochondrial repair and efficient ATP production (FDA accelerated approval for Barth syndrome, Sep 2025; other uses still in trials).
  • What the evidence isReal, registered human trials — and the most instructive mixed record in the Vault.
  • What to watchHard, hot or spreading skin at an injection site.

How SS-31 works

SS-31 does not scavenge a free radical, does not donate an electron, and does not enter the mitochondrion because of the membrane potential. It binds a lipid.

The molecule. SS-31, developed as elamipretide, is a tetrapeptide with an alternating aromatic-cationic motif: D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2',6'-dimethyltyrosine. Three features matter.

  • Injectable
  • Nasal

On the goal map: Mitochondrial ATP production (Energy & fatigue)

Research on SS-316 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: FDA accelerated approval for Barth syndrome (Forzinity, Sep 2025); other uses still in trials.

Human clinical evidence

  • Real, registered human trials — and the most instructive mixed record in the Vault. Elamipretide (the drug name for SS-31) has been through multiple phase 2 and phase 3 programs in primary mitochondrial myopathy, Barth syndrome and dry AMD.

  • MMPOWER-3 in primary mitochondrial myopathy missed its primary endpoint — six-minute walk distance. What that miss means is worth being careful about. Primary mitochondrial myopathy is an umbrella over dozens of distinct genetic defects, and a walk test is a blunt instrument for a population that heterogeneous; the earlier MMPOWER-2 crossover had shown a signal on the same measure, and patient-reported fatigue moved in the direction of benefit.

  • The Barth syndrome program — a single, defined cardiolipin-remodeling defect, which is exactly what the mechanism targets — reported functional improvement, and on 19 September 2025 the FDA granted accelerated approval to Forzinity (elamipretide) injection for Barth syndrome in patients weighing at least 30 kg, on improved knee-extensor muscle strength, with a confirmatory placebo-controlled trial required (FDA, 19 Sep 2025). It is the first drug approved for Barth syndrome. That contrast is the actual lesson: the compound did better in the population its mechanism predicts, and worse in the one that was mostly a diagnostic category.

Correlative data

  • Research-community use for mitochondrial and recovery goals. Reported experience is subtle — as expected for something targeting an organelle rather than a symptom.

How the mechanism reads

  • A tetrapeptide that concentrates in the inner mitochondrial membrane and binds cardiolipin — the phospholipid that organizes the electron transport chain. Stabilizing cardiolipin is proposed to improve ATP production and reduce electron leak.

    Mechanistic
  • The mechanism predicts where it should work best: tissues where mitochondrial dysfunction is the actual bottleneck. That is also why the trials succeeded in a rare cardiolipin-remodeling disease and struggled in broader populations.

    Mechanistic

Sources

  • Tung C, et al. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential. International Journal of Molecular Sciences 2025 · PMID 39940712
  • Sabbah HN. Contemporary insights into elamipretide's mitochondrial mechanism of action and therapeutic effects. Biomedicine and Pharmacotherapy 2025 · PMID 40294492
  • Roshanravan B, et al. PLOS ONE 2021 · PMID 34264994
  • Reid Thompson W, et al. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism. Genetics in Medicine 2021 · PMID 33077895
  • Zhu Y, et al. SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease. Oxidative Medicine and Cellular Longevity 2022 · PMID 35707274

SS-31 safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Active cancer: restoring mitochondrial ATP efficiency also helps tumor cells.
  • Hypersensitivity to elamipretide or its formulation.
  • Pregnancy or breastfeeding: no data outside Barth syndrome trials.
  • Bleeding disorder or anticoagulant use: repeated injections bruise more.

What’s expected

  • Injection-site reactions are common with this peptide.
  • Less fatigue and better exercise tolerance if cardiolipin repair works for you.
  • Mild headache while using SS-31.

Watch for

  • Hard, hot or spreading skin at an injection site.
  • Hives or breathlessness.
  • Palpitations or new heart failure signs.
  • Fever while using SS-31.

Labs that tell you it’s working

  • Coenzyme Q10
  • Carnitine, Total and Free
  • High-Sensitivity Troponin T
  • Comprehensive Metabolic Panel (CMP)

Elamipretide binds cardiolipin to stabilize inner-membrane cristae; it is approved for Barth syndrome, and mitochondrial and cardiac labs track effect. PMID 33077895 PMID 39940712

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

SS-31 FAQ4 common questions

Is SS-31 approved for human use?
SS-31 is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
What is SS-31 researched for?
Mitochondrial repair and efficient ATP production (FDA accelerated approval for Barth syndrome, Sep 2025; other uses still in trials).
Which labs show whether it's doing anything?
Coenzyme Q10; Carnitine, Total and Free; High-Sensitivity Troponin T; Comprehensive Metabolic Panel: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for SS-31: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what SS-31 is. Skool covers how it is run.

Free on this page

What SS-31 is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What SS-31 is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The SS-31 lesson: the protocol, step by step, with Cam's video
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool